Charles River: Mixed Q3 As Strategic Review Disappoints

Core Viewpoint - Shares of Charles River Laboratories International, Inc. (CRL) have underperformed over the past year, with a loss of approximately 9% [1] - The stock experienced a decline of about 7% in early trading on Wednesday following the company's earnings report and a disappointing strategic update [1] Company Performance - The company reported earnings that did not meet market expectations, contributing to the stock's decline [1] - The strategic update provided by the company was also viewed as disappointing, further impacting investor sentiment [1]